Relief Therapeutics Holding SA (SWX: RLF)

RLF Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	10.73	14.56	19.24	44.76	38.06	0.13
Short-Term Investments	-	0.01	0.03	-	0.19	-
Cash & Short-Term Investments	10.73	14.57	19.27	44.76	38.25	0.13
Cash Growth	-16.20%	-24.40%	-56.96%	17.03%	29548.06%	-51.32%
Accounts Receivable	0.96	1.67	2.04	1.62	-	-
Other Receivables	-	1.17	0.21	1.13	0.07	0.09
Receivables	0.96	2.84	2.26	2.75	0.07	0.09
Inventory	0.37	0.56	0.23	0.39	-	-
Prepaid Expenses	-	0.35	0.84	6.42	3.44	0.01
Restricted Cash	-	-	-	-	5.09	-
Other Current Assets	2.65	-	-	0.65	-	0.04
Total Current Assets	14.71	18.3	22.58	54.97	46.85	0.26
Property, Plant & Equipment	2.7	2.97	2.69	2.54	-	-
Goodwill	-	0.55	7.02	8.66	-	-
Other Intangible Assets	53.39	53.87	155.9	183.64	30.8	19.6
Long-Term Deferred Tax Assets	-	0.59	0.5	1.74	-	-
Other Long-Term Assets	0.12	0.12	0.11	0.08	-	-
Total Assets	70.92	76.39	188.8	251.62	78.05	19.86
Accounts Payable	1.29	1.03	1.63	1.7	1.43	0.28
Accrued Expenses	-	2.84	2.98	4.2	3.88	0.27
Short-Term Debt	-	1.36	1.28	1.32	0.89	1.74
Current Portion of Long-Term Debt	0.01	0.34	0.37	0.03	-	-
Current Portion of Leases	0.39	0.52	0.44	0.33	-	-
Current Income Taxes Payable	-	-	-	-	-	0.08
Current Unearned Revenue	-	0.11	0.78	-	-	-
Other Current Liabilities	3.07	0.72	3.24	12.16	0.49	0.46
Total Current Liabilities	4.76	6.91	10.72	19.73	6.69	2.82
Long-Term Debt	-	0.01	0.02	0.4	-	-
Long-Term Leases	2.02	2.09	2.23	2.19	-	-
Long-Term Deferred Tax Liabilities	7.34	7.37	20.74	25.5	4.31	2.74
Other Long-Term Liabilities	6.47	6.2	7.91	19.47	-	-
Total Liabilities	21.65	24.16	43.38	70.09	11	5.57
Common Stock	1.4	56.16	56.16	44.13	32.47	21.14
Additional Paid-In Capital	-	214.18	215.69	207.52	68.55	20.45
Retained Earnings	-222.79	-218.26	-119.6	-69.75	-35.2	-27.51
Treasury Stock	-0.15	-6	-12.11	-3	-	-
Comprehensive Income & Other	270.8	6.15	5.27	2.63	1.23	0.21
Shareholders' Equity	49.27	52.23	145.42	181.53	67.04	14.3
Total Liabilities & Equity	70.92	76.39	188.8	251.62	78.05	19.86
Total Debt	2.42	4.31	4.34	4.26	0.89	1.74
Net Cash (Debt)	8.31	10.25	14.92	40.5	37.36	-1.61
Net Cash Growth	0.74%	-31.28%	-63.16%	8.41%	-	-
Net Cash Per Share	0.67	0.87	1.41	4.51	6.19	-0.31
Filing Date Shares Outstanding	12.55	12.54	11.01	10.28	8.43	5.28
Total Common Shares Outstanding	12.55	12.54	11.01	10.28	8.12	5.28
Working Capital	9.95	11.4	11.87	35.24	40.16	-2.56
Book Value Per Share	3.92	4.16	13.20	17.65	8.26	2.71
Tangible Book Value	-4.13	-2.19	-17.5	-10.77	36.24	-5.3
Tangible Book Value Per Share	-0.33	-0.17	-1.59	-1.05	4.47	-1.00

Source: S&P Capital IQ. Standard template. Financial Sources.